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Clinical impact of the use of additional
ultrasonography in diagnostic breast imaging
Abstract The degree of adherence
with evidence-based guidelines for the
use of breast ultrasonography was
determined in clinical practice of
radiologists in six hospitals. Addi-
tional ultrasonography was performed
in 2,272 (53%) of all 4,257 patients
referred for mammography. High
adherence rates (mean: 95%) were
observed for guidelines recommend-
ing ultrasonography in patients
referred for palpable breast masses
and abnormal screening and diagnos-
tic mammograms. Lower adherence
rates (mean: 81%, Pearson correlation
coefficient=−0.57; p=0.001) were
found for guidelines advising against
additional ultrasonography in patients
referred for breast symptoms, a known
benign abnormality, a family history
or anxiety of breast cancer. The over-
use of ultrasonography in 442 patients
and underuse in 95 patients led to five
additional false-positive results. It was
concluded that the guidelines seem
workable and feasible in clinical
practice and that the current daily
routine of diagnostic breast imaging
corresponded to a great extent to the
guidelines proposed.
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Introduction
Inappropriate use of diagnostic imaging tests may result
in unnecessary workup because of false-positive test
results, unnecessary radiation exposure, inconvenience
and discomfort to patients and increasing health-care
costs. Results of studies in the USA and the Netherlands
suggest that about 30–40% of patients do not receive
health-care services according to present scientific
evidence, and about 20–25% of health services provided
is not necessary or is potentially harmful [1]. High-
quality health care, however, implies a practice that is
consistent with evidence-based medicine that provides a
framework on which clinicians can base their practice
[2, 3].
In diagnostic breast imaging, mammography is the
standard imaging tool and can be followed by breast
ultrasonography when clinically indicated. In the last 2
decades, the contribution of ultrasonography in the imag-
ing process has improved. Evidence from prospective
clinical studies shows that selective use of ultrasonography
as an adjunct to mammography can enhance the imaging
sensitivity and specificity of breast cancer diagnostics [4,
5]. Based on these studies, evidence-based guidelines were
developed, according to which breast ultrasonography can
be used more efficiently and appropriately. Practice
according to these guidelines is expected to lead to a
better accuracy of diagnostic breast imaging.
In order to encourage evidence-based practice and
improve guideline adherence by radiologists, investments
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can be made in implementation interventions. In order to
assess the need for such implementation activities, a good
analysis of actual performance and the target group and
setting is important. A measurement of current practice
identifies where it does match and does not match the
desired routines proposed by a guideline [6]. However, no
empirical data were available yet on the variability of the
application of breast ultrasonography in daily practice by
radiologists in the Netherlands.
Therefore, the aim of this study was to determine the
degree of adherence of radiologists with the proposed
guidelines in daily clinical practice. Furthermore, the
consequences of deviating from the guidelines were
studied in terms of clinical outcome measures.
Patients and methods
Study population
A retrospective multicenter study was performed in two
university hospitals (Maastricht University Hospital,
Leiden University Medical Center) and four teaching
hospitals (AtriumMedical Center Heerlen, Viecuri Medical
Center Venlo, Catharina Hospital Tilburg and Sint
Elisabeth Hospital Eindhoven) with a special interest in
breast cancer diagnostics. The medical ethics committee of
each hospital approved the study. In order to take the
privacy of these hospitals into account, the data in this
study were coded and reported anonymously.
All hospitals perform mammography and have directly
accessible ultrasonography equipment.
All patients referred for mammography to the radiology
departments of the participating hospitals during 4 months
in 2004 were eligible for the study. The months May, June,
October and November were selected to represent common
clinical practice allowing for possible seasonal effects.
Patients were included in the study if they were female,
older than 30 years of age and if the first imaging technique
applied was mammography. Patients were excluded from
the study if they had a prior history of breast cancer, had
breast implants or if the reason for referral was not
mentioned or fell beyond the scope of the guidelines. If a
patient underwent mammography more then once during
the study period, additional mammographic examinations
were included as new cases.
Guidelines
Current practice was compared to recommended practice
from guidelines. The following set of guidelines for the use
of breast ultrasonography was based on scientific evidence
from the literature [4, 5, 7], Dutch national guidelines for
breast cancer screening and diagnosis [8], practice guide-
lines from the American College of Radiology [9] and
expert opinion of breast radiologists in the participating
hospitals in this study:
Breast ultrasonography is recommended as an adjunct to
mammography and clinical breast examination in:
1. patients referred for a palpable breast mass (guideline 1);
2. patients referred with an abnormal screening mammo-
gram from the national breast cancer screening
program (guideline 2);
3. patients with an abnormal diagnostic mammogram,
defined as a mammographic new or increased mass,
architectural distortion or asymmetric density that
requires further diagnostic evaluation (guideline 3);
Breast ultrasonography is not recommended as an adjunct
to mammography and clinical breast examination in:
4. patients referred for follow-up of a (probably) benign
breast abnormality (guideline 4);
5. patients referred for symptomatic complaints, such as
pain, skin or nipple abnormalities (guideline 5);
6. patients referred for positive family history or anxiety
for breast cancer (guideline 6).
The basic principle of these guidelines was the reason for
referral for mammography (guidelines 1–2–4–5–6). In
patients with no indication for breast ultrasonography
based on their reason for referral (guidelines 4–5–6), the
findings at the initial diagnostic mammography could still
provide this indication (guideline 3). A flow chart of the
procedures and guidelines is shown in Fig. 1.
Data collection
Medical records of all eligible patients were collected and
analyzed by the principal investigator (LV). For all patients
meeting the inclusion criteria the subsequent items were
scored: age, reason for referral, detected abnormalities at
mammography, imaging techniques used, imaging conclu-
sion (of mammography alone or combined with ultraso-
nography when available) and the BI-RADS classification.
The BI-RADS lexicon is a standardized terminology in
mammography and ultrasonography reporting and uses a
grading scale of increasing suspicion for breast malignancy
[10]. A final diagnostic conclusion was defined positive if a
BI-RADS classification score of 3, 4 or 5 was ascribed, a
follow-up imaging examination was recommended or fine-
needle aspiration cytology or core-needle biopsy was
indicated.
The gold standard for the presence or absence of breast
cancer was determined by pathology results from histo-
logical breast tissue examination from biopsies or surgical
excisions after a follow-up of 12 months. Pathology data
were retrieved from the nationwide network and registry of
histo- and cytopathology in the Netherlands (PALGA), to
which all Dutch hospital pathology departments are linked.
Breast cancer status was considered negative when no
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The degree of adherence to the guidelines was reflected by
the percentage of patients for whom the radiologists were
complying with the proposed guidelines. The adherence
rate was calculated by dividing the number of patients
referred for breast imaging who were treated by the
radiologist according to the guidelines by the total number
of patients referred for breast imaging. Next to the overall
adherence rate per hospital, adherence rates were calculated
for guidelines 1–2–3 (ultrasonography is recommended),
guidelines 4–5–6 (ultrasonography is not recommended),
per guideline per hospital and per radiologist (performing at
least 50 mammograms).
Clinical outcome
The following clinical outcome measures were calculated
by linking the diagnostic imaging conclusions with the
pathology data: numbers of true-positive diagnostic
conclusions, true-negative diagnostic conclusions, false-
positive diagnostic conclusions and false-negative diag-
nostic conclusions. All false-negative and false-positive
imaging results were reviewed, and the nature of the
diagnostic conclusions was classified [11].
Furthermore, breast cancer prevalence rates, imaging
sensitivity and specificity as well as the positive predictive
value (PPV), negative predictive value (NPV) and diag-
nostic odds ratios (DOR’s) were reported. The DOR
combines the sensitivity and specificity into one estimate
and can be derived by dividing the odds of a positive test
result among diseased persons by the odds of a positive test
result among non-diseased persons ((sensitivity/(1-sens)) *
(specificity/(1-spec))) [12].
Analysis
Pearson’s correlation coefficients were calculated to
analyze the strength of the linear relationship between the
following variables: adherence rate for guidelines 1–2–3
and adherence rate for guidelines 4–5–6 at the radiologist
level; adherence rate for guidelines 1–2–3 and guidelines
4–5–6 and the corresponding DORs at the hospital level.
Furthermore, the influence of patient age and breast cancer
prevalence on the adherence rates was studied by regres-
sion analysis. Statistical analyses were performed using the
software package SPSS 13.0.
Results
General
Of the 9,172 patients referred for mammography and
assessed for eligibility, 4,915 patients were excluded
because of a prior history of breast cancer (n=2,948), a
reason for referral beyond the scope of the guidelines (n=
769), ultrasonography being the first or only imaging

































or age younger than 30 years (n=251). Consequently,
4,257 patients were included in the study.
The number of included patients per center in the study
period varied between 522 and 1,117 patients (mean, n=
710). The mean age of the total study population was
50 years and varied between 48–52 years among the
hospitals.
Adherence rates
Overall, breast ultrasonography was applied as an adjunct
to mammography in 2,272 patients (53%). The distribution
of the study population over the six guidelines and the
corresponding adherence rates are demonstrated in Table 1.
Of all patients, 33% was referred for a palpable breast mass
(n=1,408), 30% was referred for a family history or anxiety
for breast cancer (n=1,245), 17% was referred because of
symptomatic breast complaints (n=725), 9% was referred
for the follow-up of a known benign breast abnormality
(n=362) and 7% was referred from the national breast
cancer screening program (n=305).
Furthermore, in 212 patients (5%) the indication for
breast ultrasonography was caused by an abnormal prior
diagnostic mammography, specified as guideline 3. The
reason for referral of these patients was a family history or
anxiety for breast cancer in 79 cases (37%), the follow-up
of a known benign breast abnormality in 57 patients (27%),
pain in 46 cases (22%) and nipple or skin abnormalities in
30 patients (14%). Patients with abnormal mammograms
who were referred with a palpable breast mass or an
abnormal screening mammogram were not included in
guideline 3, but fell under guidelines 1 and 2, respectively
(Fig. 1).
High adherence rates (74%-100%, mean: 95%) were
observed for the different guidelines that advise ultra-
sonography (guidelines 1–2–3), whereas lower adherence
rates (44%–99%, mean: 81%) were found for the different
guidelines that do advise against additional ultrasonogra-
phy (guidelines 4–5–6). A negative correlation indicates a
mutual dependence within the guidelines, as adhering well
on guidelines 1–2–3 implicates lower adherence on
guidelines 4–5–6; Pearson correlation coefficientwas-
0.57; p=0.001.
Furthermore, the overall guideline adherence rates per
hospital varied between 79% and 92% (mean: 87%). The
adherence rates for the different participating radiologists
within the hospitals were relatively consistent; the differ-
ences were not statistically significant (results not shown).
In order to study the influence of patient age and breast
cancer prevalence on the adherence rates, regression
analysis was performed. Results show that age was a
statistically significant predictor of the adherence rate for
both guidelines 1–2–3 (β=−0.001, p=0.03) and guidelines
4–5–6 (β=0.002, p=0.017). Breast cancer prevalence was
also a predictor of the adherence rates for guidelines 1–2–3
(β=0.82, p=0.15) and for guidelines 4–5–6 (β=−5.59, p=
0.5), although its influence was not statistically significant.
Clinical outcome
The clinical outcome measures of this study are reported in
Table 2. Overall, breast cancer was detected in 323 patients
Table 1 Adherence rates per hospital per guideline (GL) and per set of guidelines (GL1–3: ultrasonography is recommended and GL4–6:
ultrasonography is not recommended)
Hospital Ultrasonography recommended Ultrasonography not recommended Total
GL 1 GL 2 GL 3 GL 1–3 GL 4 GL 5 GL 6 GL 4–6
A N 195 68 36 299 27 118 148 293 592
Adherence 100% 100% 94% 99% 67% 76% 92% 83% 91%
B N 379 42 43 464 106 236 311 653 1,117
Adherence 96% 98% 98% 97% 44% 58% 79% 66% 79%
C N 277 75 44 396 58 105 280 443 839
Adherence 94% 91% 95% 94% 78% 73% 96% 88% 91%
D N 178 19 26 223 36 64 199 299 522
Adherence 87% 74% 88% 86% 97% 86% 99% 96% 92%
E N 164 74 38 276 88 80 123 291 567
Adherence 95% 91% 97% 94% 88% 78% 91% 86% 90%
F N 215 27 25 267 47 122 184 353 620
Adherence 99% 100% 96% 99% 64% 75% 90% 81% 89%
Total N 1,408 305 212 1,925 362 725 1,245 2,332 4,257
Adherence 95% 93% 96% 95% 69% 72% 91% 81% 87%
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(7.6%); 307 cases were found under guidelines 1–2–3 and
16 cases were found under guidelines 4–5–6.
For the patients in guidelines 1–2–3, the breast imaging
sensitivity ranged from 95–100% (mean=98%), and
specificity ranged from 71–95% (mean=88%). Further-
more, for the patients in guidelines 4–5–6, the breast
imaging sensitivity ranged from 20–50% (mean=25%) and
specificity ranged from 93–100% (mean=98%). Combin-
ing the sensitivity and specificity values in a DOR showed
higher logDOR values for the imaging results in guidelines
1–2–3 (range=4.2–8.0; mean=6.1) compared to guidelines
4–5–6 (range=1.5–5.2; mean=2.9). Similarly, the PPV
ranged from 56–81% (mean=60%) in guidelines 1–2–3
compared to 3–60% (mean=9%) in guidelines 4–5–6. The
NPV ranged from 99–100% for both groups of guidelines.
Among the participating hospitals the overall sensitivity
and specificity of diagnostic breast imaging varied between
91–97% and 84–98%, respectively. Local breast cancer
prevalence rates ranged from 5.0% to 9.9%.
The relationship between guideline adherence rates and
clinical outcome was studied by correlation coefficients.
The hospital adherence rate for guidelines 1–2–3 was
positively correlated with logDOR, but this was not statis-
tically significant (Pearson correlation coefficient=0.42; p=
0.40). On the other hand, the adherence rate for guidelines
4–5–6 was negatively correlated with logDOR (Pearson
correlation coefficient=−0.69; p=0.13). Furthermore, it was
shown that the hospitals with the lowest guideline adherence
rate for guidelines 4–5–6 had the highest corresponding
logDOR (see hospital B and F in Table 2).
Overall, in 4,257 patients 17 false-negative (0.4%) and 240
false-positive (5.6%) imaging conclusions were found. In
Tables 3 and 4 the characteristics of these cases are described.
In 11 cases of the false-negative imaging conclusions, the
mammographic signs of malignancy were overlooked or
misinterpreted, whereas in the other 6 cases the malignancy
was undetectable, occult or had non-specific signs of
abnormality. The majority (82%) of the false-positive
Table 2 Clinical outcome measures
Hospital A B C D E F Overall
Ultrasonography is recommended N 299 464 396 223 276 267 1,925
Adherence 99% 97% 94% 86% 94% 99% 95%
Prevalence 17% 18% 11% 11% 20% 19% 16%
FP 29 20 32 34 65 19 199
TP 51 84 40 25 53 49 302
FN 0 0 2 0 2 1 5
TN 219 360 322 164 156 198 1,419
Sensitivity 100% 100% 95% 100% 96% 98% 98%
Specificity 88% 95% 91% 83% 71% 91% 88%
Log DOR 6.6 8.0 5.3 5.5 4.2 6.2 6.1
PPV 64% 81% 56% 42% 45% 72% 60%
NPV 100% 100% 99% 100% 99% 99% 100%
Ultrasonography is not recommended N 293 653 443 299 291 353 2,332
Adherence 83% 66% 88% 96% 86% 81% 81%
Prevalence 0.68% 0.61% 0.45% 0.33% 0.34% 0.17% 0.69%
FP 3 2 4 11 19 2 41
TP 0 1 0 0 0 3 4
FN 2 3 2 1 1 3 12
TN 288 647 437 287 271 345 2,275
Sensitivity 20% 25% 20% 33% 33% 50% 37%
Specificity 99% 100% 99% 96% 93% 99% 98%
Log DOR 2.8 4.7 3.0 2.1 1.5 5.2 2.9
PPV 14% 33% 11% 4% 3% 60% 9%
NPV 99% 100% 100% 100% 100% 99% 99%
Total N 592 1,117 839 522 567 620 4,257
Overall prevalence 9% 7.9% 5.2% 5% 9.9% 9% 7.6%
Overall sensitivity 96% 97% 91% 96% 95% 93% 95%
Overall specificity 94% 98% 95% 91% 84% 96% 94%
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imaging resultswere due tomisinterpretation of the lesion, an
asymmetric density or an architectural distortion.
In 95 patients, radiologists failed to adhere to guide-
lines 1–2–3 (breast ultrasonography was indicated but
not performed), but this course of action did not lead to
false-negative imaging results. In 442 patients, radiolo-
gists deviated from guidelines 4–5–6 (breast ultra-
sonography was not indicated but performed), which
resulted in five additional false-positive results and one
true-positive finding, which was classified as benign by
mammography.
Discussion
This study demonstrated that in the two university hospitals
and four teaching hospitals the application of additional
breast ultrasonography in daily clinical practice corre-
sponded well with the guidelines proposed. The overall
guideline adherence was 87% and varied among the
hospitals between 79% and 91%. The mean adherence with
guidelines 1–2–3, which recommend additional ultra-
sonography in patients referred for palpable breast masses
and abnormal screening and diagnostic mammograms, was
95%. Furthermore, the mean adherence with guidelines
4–5–6, which do advise against breast ultrasonography in
patients referred for other breast symptoms, follow-up of a
known benign abnormality, a family history or anxiety of
breast cancer, was 81%.
It is likely that a radiologist who is more reserved in
applying breast ultrasonography shows relatively lower
adherence rates for guidelines 1–2–3 and relatively
higher adherence rates for guidelines 4–5–6 as a
consequence. Furthermore, a radiologist who is more
sensitive to defensive diagnostic imaging will apply
ultrasonography more often and will show higher
adherence rates for guidelines 1–2–3 and lower adher-
ence rates for guidelines 4–5–6. This mutual depen-
dence within the guidelines was illustrated by a negative
Table 3 False-negative imaging results (n=17)
Reason for referral Age Hospital Imaging result
after mammogram




Palpable abnormality 37 E Negative Negative A
Abnormal screening mam. 52 C Negative Negative A
Pain 51 C Positive Negative B
Pain 72 E Positive Negative A
Follow-up lesion 55 F Negative Negative A
Follow-up lesion 73 A Negative No US performed B
Follow-up lesion 62 C Negative No US performed A
Nipple retraction 52 F Positive Negative A
Nipple discharge 69 C Negative Negative A
Nipple discharge 33 B Negative No US performed C
Positive family history 63 D Negative No US performed D
Positive family history 56 F Negative No US performed D
Positive family history 67 F Negative No US performed A
Positive family history 49 A Negative No US performed A
Positive family history 48 B Negative No US performed B
Positive family history 45 B Negative No US performed A
Positive family history 59 E Negative No US performed A
*Classification categories false-negative results:
A = Mammographic signs of malignancy were overlooked or misinterpreted
B = Minimal or non-specific signs of abnormality
C = Malignancy was mammographically occult
D = Malignancy was mammographically undetectable
Table 4 False-positive imaging results (n=240)




1 99 47 97 2
2 60 58 43 17
3 40 50 40 0
4 24 57 11 13
5 8 59 5 3
6 9 52 0 9
Total 240 196 44
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correlation between the adherence rates of the two
subgroups of guidelines.
Although no scientific literature is available on bench-
mark adherence rates of radiologists with guidelines on
diagnostic breast imaging, the results of this study can be
compared to studies on other physicians’ adherence rates
with clinical guidelines. Burstin et al. [13] reported an
adherence rate of 60.4% with different process-of-care
guidelines in emergency medicine. Furthermore, in a meta-
analysis on 23 studies, Grilli and Lomas [14] reported a
mean adherence rate of 54.5% with 147 clinical recom-
mendations. Another study in the Netherlands on 70
evidence-based guidelines in family medicine found a
mean adherence rate of 67% (range: 34%–100%) [15]. It is
obvious that the adherence rates found in the current study
were much higher than in the studies reported.
The overall breast cancer prevalence (7.6%) found in
this study was comparable to the prevalence reported by
Duijm et al. (5%), Flobbe et al. (6%) and Zonderland et al.
(7%) [4, 5, 16]. There was a substantial variation in
prevalence among the hospitals, with lower prevalences
found in hospitals C and D. Although the distribution of
patients over the different guidelines was comparable for
all hospitals, the difference in prevalence could be
explained by a variation in the composition of the study
population. In hospital C, the proportion of malignancies
was relatively low among patients referred for a palpable
mass (6.9% versus 11.8% on average) and patients with an
abnormal screening mammogram (21.3% versus 38.5% on
average). In hospital D, the proportion of malignancies for
patients with an abnormal diagnostic mammogram (guide-
line 3) was low (3.8% versus 14.8% on average).
Although the correlation between the adherence rates for
guidelines 1–2–3 and guidelines 4–5–6 with the corre-
sponding breast cancer prevalence was not statistically
significant, the difference between both regression coeffi-
cients (+0.82 and -5.59, respectively) does indicate that
more frequent use of breast ultrasonography is related to a
higher breast cancer prevalence.
The sensitivity of breast imaging varied among the
hospitals between 91% and 97% (mean: 95%), and the
specificity varied between 84% and 98% (mean: 94%).
These rates are comparable to the imaging accuracy found by
Flobbe et al., Zonderland et al. and Duijm et al. [5, 16, 17].
Overall, breast ultrasonography was applied as an
adjunct to mammography in 53% of all patients included.
Based on the guidelines in this study, its performance was
recommended in 43% of this patient population
(1,925/4,257). It should be noted, however, that, as
evidence-based guidelines are meant to direct professionals
in their decision-making rather than to prescribe compul-
sory actions, an aim of 100% guideline adherence would be
unrealistic and undesirable.
Non-adherence with the guidelines that recommend
breast ultrasonography is expected to lead to an increase in
the number of missed breast cancer diagnoses, or false-
negative imaging results. Furthermore, non-adherence with
the guidelines that advise against ultrasonography would
have an effect on the number of false-positive results. In
this patient population, breast ultrasonography was under-
used in 95 patients, but this did not result in false-negative
results. Furthermore, breast ultrasonography was overused
in 442 patients, which resulted in five false-positive and
one additional true-positive result. These numbers are low
compared to other studies and could be partly explained by
a difference in study design and methodology [4, 18].
Although ultrasonography is a relatively cheap and
accessible imaging test and its overuse did not lead to many
false-positive results here, there is a concern that the
radiologists with lower adherence to guidelines 4–5–6
would induce a general overuse of imaging tests due to
defensive diagnostics. This could lead to large numbers of
unnecessary time- and labor-intensive and costly radiolog-
ical procedures. For example, the pursuit of false-positive
CT findings in lungs is at best costly, anxiety producing
and involves 2 years of repeated CT scans. At worst, it will
lead to painful, costly and potentially risky major surgical
procedures [19].
It was assumed that the guideline adherence rate was
positively correlated with the breast imaging performance.
This was confirmed for guidelines 1–2–3; for guidelines 4–
5–6, a negative correlation was found between adherence
and the DOR. These results suggest that performing more
breast ultrasonography would generally lead to better
imaging performance. This finding confirms prior study
results by Flobbe et al., who report the sensitivity
increasing from 91.5% to 96.9% and the specificity
increasing from 87% to 94.8% by applying breast ultraso-
nography in all patients referred for mammography. In
clinical practice, however, breast ultrasonography should
be restricted mainly to the patient groups in guidelines 1–
2–3, which will lead to a more efficient, time- and labor-
saving and cost-effective use of the imaging test [4, 5, 7].
Furthermore, results showed a negative relationship
between age and guideline adherence for guidelines 1–2–3
and a positive relationship between age and guideline
adherence for guidelines 4–5–6, indicating that the use of
ultrasonography decreases by age. Several studies have
reported lower sensitivity for mammography at younger
age [20, 21] and a related higher additional value for
ultrasonography [22]. Furthermore, the effectiveness of
whole breast ultrasonography in women with dense breast
tissue and negative mammograms [23–25] may have
favored the performance of ultrasonography in younger
women, since breast density declines by age.
A possible methodological limitation of this study is the
retrospective nature of data collection. The lacking of
abnormalities in mammogram reports could either be
because they were actually not existing or because they
were not registered. Furthermore, some breast findings
were excluded from analysis because of missing data (e.g.,
breast density scores and comparison with previous
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mammograms). A prospective study design with standar-
dized data collection would prevent this study bias.
Secondly, a selection bias may occur since only hospitals
with a special interest in breast cancer diagnostics were
involved. Inclusion of other hospitals could possibly lead
to a lower level of guideline adherence.
In this study the measurement of current practice was
performed in order to assess the need for guideline
implementation activities, by which evidence-based prac-
tice could be encouraged. The high adherence rates,
however, indicate that these specific guidelines in this
setting are less suitable for investments by guideline
implementation activities. However, publication of these
study results leads to dissemination of the guidelines
among radiologists and other relevant target groups, which
can be considered as a guideline implementation strategy
by itself. An increased awareness of radiologists of current
practice and better knowledge of the guidelines could then
lead to a further enhancement of the adherence rates.
Nevertheless, this study has revealed new and valuable
information about current radiology practice in relation to
the proposed guidelines. The results show that the guide-
lines for appropriate use of breast ultrasonography that
have been developed seem workable and feasible in
clinical practice. It can be concluded that current daily
practice of diagnostic breast imaging corresponded to a
great extent to these guidelines proposed.
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